Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 29, 2022
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
[ Thu, Sep 29th 2022
] - WOPRAI
Wed, September 28, 2022
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
Evan Seigerman Upgraded (BIIB) to Buy and Increased Target to $360 on, Sep 28th, 2022
Evan Seigerman of BMO Capital, Upgraded "Biogen Inc." (BIIB) to Buy and Increased Target from $217 to $360 on, Sep 28th, 2022.
Evan has made no other calls on BIIB in the last 4 months.
There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 2 agree with Evan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Paul Matteis of "Stifel" Maintained at Hold with Decreased Target to $223 on, Monday, September 12th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $200 on, Thursday, July 21st, 2022
These are the ratings of the 4 analyists that currently disagree with Evan
- Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $265 on, Thursday, September 22nd, 2022
- Phil Nadeau of "Cowen & Co." Maintained at Buy with Decreased Target to $270 on, Thursday, July 21st, 2022
- Ami Fadia of "Needham" Maintained at Strong Buy with Decreased Target to $250 on, Thursday, July 21st, 2022
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $230 on, Monday, July 18th, 2022
